Antiretroviral therapy (ART) has evolved considerably over the past three decades. With many antiretroviral (ARV) drugs, combinations, and classes available, health care providers have multiple choices regarding ARV therapy. While these choices provide health care providers with many options, they also lead to challenges. One of the biggest challenges for clinicians is individualizing the care of HIV-positive patients and understanding when certain ARV therapies and strategies are appropriate, and when they are not. Numerous studies have shown that ARV therapy must be tailored to the individual patient and his or her abilities and diverse needs. A "cookie-cutter" or "one size fits all" approach can lead to poor outcomes, with higher rates of virologic failure and ARV-related toxicities. With the wealth of choices available, the challenge for health care providers remains weighing the relative benefits and risks of each ARV and ARV combination and creating an appropriate ARV regimen that is potent, tolerable, safe, and durable. By participating in this online program, clinicians and other health care providers will gain the tools they need to reduce morbidity and mortality and improve outcomes of HIV patients.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals actively involved in the treatment and management of patients with HIV-infection. It is tuition-free and there are no prerequisites.
Upon completion of the program, participants should be better able to:
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
Joseph Eron, MD
Professor
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Supported by an Independent Educational Grant by Merck & Co.
